Literature DB >> 25139038

Balance of antiangiogenic and angiogenic factors in the context of the etiology of preeclampsia.

Hiroyuki Seki1.   

Abstract

The "two-stage disorder" theory that is assumed for the etiology of preeclampsia hypothesizes that antiangiogenic and angiogenic factors and/or placental debris play an important role in this disorder. The physiological actions of placental debris occur via the balance between antiangiogenic and angiogenic factors. Accordingly, this balance between antiangiogenic and angiogenic factors should be investigated to elucidate the various pathological features of preeclampsia. Their accurate evaluation is needed to investigate not only antiangiogenic factors (such as sFlt-1 and sEng) and angiogenic factors (such as vascular endothelial growth factor, placental growth factor and transforming growth factor-β) but also the expression level of their receptors such as Flt-1 and Eng. However, it is ethically and technically difficult to investigate the above-mentioned factors at antepartum in human patients. The examination of the ratios of sFlt-1/vascular endothelial growth factor receptor ligands and sEng/transforming vascular endothelial growth factor-β and the use of experimental animal models may help in elucidating various unresolved issues in preeclampsia.
© 2014 Nordic Federation of Societies of Obstetrics and Gynecology.

Entities:  

Keywords:  Two-stage disorder; antiangiogenic factors; etiology; preeclampsia; sEng; sFlt-1; trophoblasts

Mesh:

Substances:

Year:  2014        PMID: 25139038     DOI: 10.1111/aogs.12473

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  10 in total

Review 1.  Recent Advances in Hypertension and Cardiovascular Toxicities With Vascular Endothelial Growth Factor Inhibition.

Authors:  Rhian M Touyz; Ninian N Lang; Joerg Herrmann; Anton H van den Meiracker; A H Jan Danser
Journal:  Hypertension       Date:  2017-06-19       Impact factor: 10.190

Review 2.  The emerging role of endothelin-1 in the pathogenesis of pre-eclampsia.

Authors:  Langeza Saleh; Koen Verdonk; Willy Visser; Anton H van den Meiracker; A H Jan Danser
Journal:  Ther Adv Cardiovasc Dis       Date:  2016-01-10

Review 3.  VEGF Receptor Inhibitor-Induced Hypertension: Emerging Mechanisms and Clinical Implications.

Authors:  Nicholas Camarda; Richard Travers; Vicky K Yang; Cheryl London; Iris Z Jaffe
Journal:  Curr Oncol Rep       Date:  2022-02-18       Impact factor: 5.945

4.  Placental Growth Factor, Soluble fms-Like Tyrosine Kinase 1, Soluble Endoglin, IL-6, and IL-16 as Biomarkers in Preeclampsia.

Authors:  Carmen Rădulescu; Anca Bacârea; Adina Huțanu; Rozalia Gabor; Minodora Dobreanu
Journal:  Mediators Inflamm       Date:  2016-10-05       Impact factor: 4.711

Review 5.  Pathogenesis of Preeclampsia and Therapeutic Approaches Targeting the Placenta.

Authors:  Manoj Kumar Jena; Neeta Raj Sharma; Matthew Petitt; Devika Maulik; Nihar Ranjan Nayak
Journal:  Biomolecules       Date:  2020-06-24

6.  Fetal growth restriction as the initial finding of preeclampsia is a clinical predictor of maternal and neonatal prognoses: a single-center retrospective study.

Authors:  Masaya Takahashi; Shintaro Makino; Kyoko Oguma; Haruka Imai; Ai Takamizu; Akari Koizumi; Koyo Yoshida
Journal:  BMC Pregnancy Childbirth       Date:  2021-10-06       Impact factor: 3.007

7.  Placental lesions and differential expression of pro-and anti-angiogenic growth mediators and oxidative DNA damage marker in placentae of Ghanaian suboptimal and optimal health status pregnant women who later developed preeclampsia.

Authors:  Enoch Odame Anto; David Antony Coall; Emmanuel Akomanin Asiamah; Osei-Owusu Afriyie; Otchere Addai-Mensah; Yaw Amo Wiafe; Wkba Owiredu; Christian Obirikorang; Max Efui Annani-Akollor; Nicholas Akinwale Titiloye; Eric Adua; Emmanuel Acheampong; Evans Asamoah Adu; Stephen Opoku; Agartha Odame Anto; Augustine Tawiah; Youxin Wang; Wei Wang
Journal:  PLoS One       Date:  2022-03-21       Impact factor: 3.240

8.  A case of hypertensive disorders of pregnancy that developed at 9 weeks of gestation.

Authors:  Saki Hayashi; Naro Ohashi; Daiki Goto; Naomi Isomura; Shinsuke Isobe; Tomoyuki Fujikura; Yoshihide Fujigaki; Akira Shimizu; Hiroaki Ito; Hideo Yasuda
Journal:  CEN Case Rep       Date:  2021-03-15

9.  Int6/eIF3e Silencing Promotes Placenta Angiogenesis in a Rat Model of Pre-eclampsia.

Authors:  Qin Li; Baolin Yao; Alexander Endler; Li Chen; Futoshi Shibasaki; Haidong Cheng
Journal:  Sci Rep       Date:  2018-06-12       Impact factor: 4.379

10.  circCRAMP1L is a novel biomarker of preeclampsia risk and may play a role in preeclampsia pathogenesis via regulation of the MSP/RON axis in trophoblasts.

Authors:  Yonggang Zhang; Hongling Yang; Yipeng Zhang; Junzhu Shi; Ronggui Chen
Journal:  BMC Pregnancy Childbirth       Date:  2020-10-27       Impact factor: 3.007

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.